Navigation Links
Bioniche Pharma Launches Ibutilide Fumarate Injection
Date:1/12/2010

LAKE FOREST, Ill., Jan. 12 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals announced today the launch of Ibutilide Fumarate Injection, the generic equivalent of Corvert® from Pfizer Inc.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO)

"The addition of Ibutilide Fumarate Injection further demonstrates Bioniche Pharma's continued growth and dedication to a consistently expanding portfolio of injectables," said George Zorich, President, US Operations for Bioniche Pharma.

Bioniche Pharma will supply Ibutilide Fumarate Injection in 0.1 mg/mL, 10mL vials.

This product has a boxed warning relating to proarrhythmic effects including potentially fatal arrhythmias (e.g., polymorphic ventricular tachycardia) and consideration for use in patients with chronic atrial fibrillation. Please refer to the Bioniche Pharma website at www.bionichepharma.com for the complete prescribing information for this product, including the boxed warning.

About Bioniche Pharma:

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets. The company's growth is fueled by an internal development pipeline and an aggressive acquisition strategy for products. Bioniche Pharma was acquired in February 2006 by RoundTable Healthcare Partners, a private equity firm based in
'/>"/>

SOURCE Bioniche Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
2. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
3. Bioniche Pharma and Academic Pharmaceuticals, Inc. Announce the Introduction of Sotalol Hydrochloride Injection
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015  Becton, Dickinson and Company (NYSE: ... commence offers to exchange all validly tendered and accepted ... a wholly owned subsidiary of BD, for notes to ... below. A Registration Statement on Form S-4 (the "Registration ... was filed with the Securities and Exchange Commission ("SEC") ...
(Date:3/26/2015)... , 26. März 2015  Die ... wird vom 1. April 2015 an Zulassungsanträge für ... abgebenden Apotheken annehmen. Seit dem Start des ... Verband über 275 .pharmacy-Domainnamen zugelassen, die für ... Zeiten beantragt wurden. Die NABP startete .pharmacy ...
(Date:3/26/2015)... -- Gelesis , a clinical stage biotechnology ... to induce weight loss and improve glycemic control, ... of shares of convertible preferred stock for gross ... of approximately $4 million of outstanding convertible promissory ... to support the continued clinical development of its ...
Breaking Medicine Technology:Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Gelesis Closes $22M Equity Financing 2Gelesis Closes $22M Equity Financing 3
(Date:3/26/2015)... FL (PRWEB) March 26, 2015 ... the nation’s leading innovative specialty pharmacies, announces the ... position of Vice President of Pharmaceutical Relations. In ... beneficial connections with our pharmaceuticals partners and providing ... in support of BioPlus’ expansion. , “Over ...
(Date:3/26/2015)... In the key developed markets, the hypertension ... is set to decrease through 2020 at a negative CAGR ... expected up to 2017 at a 2.6% CAGR and a ... to the surging penetration of fixed-dose combination drugs like Azor, ... Benicar HCT, and Tekamlo), a hike in the prevalence population ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Leading ... brand-new, state-of-the-art company website: http://www.metabolicnutrition.com . ... revamped website creates a user-friendly experience for consumers ... , The new, enhanced Metabolic Nutrition website ... about the company’s diverse line of products, conveniently ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Zane Benefits, ... businesses, announced a new eBook, “The Comprehensive Guide To ... eBook, interviewing is the most important aspect of the ... they are hiring the right way, possibly resulting in ... be an arduous undertaking, yet it’s essential to the ...
(Date:3/26/2015)... 26, 2015 LinkToBanking, a Preferred ... names Tom Fleming as Chairman of the Board ... effective immediately. With their combined knowledge and ... industry, Mr. Fleming and Mr. Casares will provide ... to cannabis related businesses. , About Tom Fleming, ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 3
... toll was so overwhelming that steam shovels were brought in ... trains commandeered to transport dead soldiers and priests could be ... threat of another flu pandemic looming in the not too ... preparations for it mortuary specialists are once more faced with ...
... babies much before the full term are administered steroids. ... the University of Adelaide , has found that subjecting ... babies by reducing potential breathing difficulties during delivery. ... babies from the Adelaide Women's and Children's Hospital. Research ...
... to introduce a system in which the GPs would be graded ... government to vote in favor for the new scheme of grading ... According to this the surgeries were to be inspected by doctors, ... one to three. It was a modification of the accreditation scheme. ...
... which is already running in a loss would have to pay ... are not in a position // to fulfil the commitment to ... health services. ,The trusts in the south of England ... ?20bn scheme under a deal with Japanese firm Fujitsu. But the ...
... Cheltenham Science Festival that it plans to send a ... //a research into the effects of low oxygen levels, ... for Aviation, Space and Extreme Environment Medicine at the ... will be conducting the research along with researchers around ...
... In a breakthrough move against HIV drug resistance, scientists have now ... that is the first in a new class of HIV drug ... Caspsid, a key viral protein from its precursor protein,this group of ... acid, and interferes with the production of the capsid conical ...
Cached Medicine News:Health News:What to do with the Dead if a Flu Outbreak Happens? 2Health News:Already Short Staffed And In Deficit NHS Fails To Supply Staff For IT Project 2Health News:Mount Everest to be Site of Research into Hypoxia 2
... to Z Drug Facts produced by ... on thousands of medications. It provides ... effect, drug interactions, patient information and ... reference for physicians, students, residents, pharmacists, ...
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
... with Integrated Calculators, based on Davis's Drug ... advance in drug reference. DDGNIC contains the ... Guide (9th Edition) and has integrated calculation ... product merges many of the advantages of ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: